GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Thoratec Corporation (THOR) [hlAlert]

Rating:
Overweight
THOR
up 135.78 %

Thoratec Corporation (THOR) rated Overweight with price target $43 by Barclays Capital

Posted on: Friday,  Sep 23, 2011  1:25 PM ET by Barclays Capital

Barclays Capital rated Overweight Thoratec Corporation (NASDAQ: THOR) on 09/23/2011. Previously Barclays Capital rated Overweight Thoratec Corporation (NASDAQ: THOR) on 11/19/2010.,
when the stock price was $26.46. Since then, Thoratec Corporation has gained 135.79% as of 08/27/2015's recent price of $62.39.
If you would have followed the previous Barclays Capital's recommendation on THOR, you would have gained 135.78% of your investment in 1742 days.

Thoratec Corporation (Thoratec) is a manufacturer of mechanical circulatory support products for use by patients with heart failure (HF). The Company develops, manufactures and markets medical devices used for circulatory support. It also develops, manufactures and markets point-of-care diagnostic test systems and skin incision products. Thoratec operates in two operating divisions: Cardiovascular and International Technidyne Corporation (ITC), a wholly owned subsidiary. The Cardiovascular segment develops, manufactures and markets medical devices used for mechanical circulatory support (MCS). ITC designs, develops, manufactures and markets point-of-care diagnostic test systems and incision products. The Company conducts business both in the United States and internationally.

Barclays Capital has assembled a world-class, award-winning team of analysts covering, credit, commodities, economics, emerging markets, equities, fixed income, foreign exchange and market strategy. We provide in-depth analysis of companies and macro coverage across asset classes, markets and the world’s economies. We have a highly quantitative approach and our research is underpinned by sophisticated analytics. Combined, these provide clients with the tools and insights necessary for successful risk management and financing. Our research teams are based in many of the world’s major financial centres providing our clients with a globally integrated perspective across products and geographies.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/23/2011 1:25 PM Buy
None
31.45 43.00
as of 12/30/2011
1 Week up  1.57 %
1 Month up  10.32 %
3 Months up  2.81 %
1 YTD up  18.50 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/19/2010 12:25 PM Buy
None
26.46 39.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy